(Q43897727)

English

Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

unstable angina

1 reference

based on heuristic

inferred from title

Manfred Wonisch

8

object named as

Manfred Wonisch

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Ronald Hödl

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kurt Huber

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Wilfried Kraxner

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mariam Nikfardjam

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Martin Schumacher

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Friedrich M Fruhwald

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Gerlinde Zorn

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Werner Klein

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

589-592

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Sandwich ELISA for t-PA antigen employing a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Limitation of vWf meta-analysis in LMWH comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902300-1

7 January 2021

Identifiers

10.1016/S0002-9149(01)02300-1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43897727&oldid=2104231645"